the drug being a ribosomal inhibitory protein,(RIP-i or RIP-II)

Industry

CPC
A61K47/48469

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

AHUMAN NECESSITIES A61Medical science A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES A61K47/00Medicinal preparations characterised by the non-active ingredients used

Current Industry

A61K47/48469the drug being a ribosomal inhibitory protein,(RIP-i or RIP-II)

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Anti-DLL3 antibody drug conjugates for treating cancer
- Patent number 10,137,204
- Issue date Nov 27, 2018
- ABBVIE STEMCENTRX LLC
- Robert A. Stull
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of delivering DLL3 antibody drug conjugates
- Patent number 9,878,053
- Issue date Jan 30, 2018
- ABBVIE STEMCENTRX LLC
- Robert A. Stull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Kits containing DLL3 antibody drug conjugates
- Patent number 9,861,708
- Issue date Jan 9, 2018
- ABBVIE STEMCENTRX LLC
- Robert A. Stull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-DLL3 antibody drug conjugates
- Patent number 9,855,343
- Issue date Jan 2, 2018
- ABBVIE STEMCENTRX LLC
- Robert A. Stull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-FZD10 monoclonal antibodies and methods for their use
- Patent number 9,777,065
- Issue date Oct 3, 2017
- Omeros Corporation
- W. Jason Cummings
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-DLL3 antibody drug conjugates for treating cancer
- Patent number 9,775,916
- Issue date Oct 3, 2017
- ABBVIE STEMCENTRX LLC
- Robert A. Stull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-DLL3 antibody drug conjugates
- Patent number 9,770,518
- Issue date Sep 26, 2017
- ABBVIE STEMCENTRX LLC
- Robert A. Stull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of making DLL3 antibody drug conjugates
- Patent number 9,764,042
- Issue date Sep 19, 2017
- ABBVIE STEMCENTRX LLC
- Robert A. Stull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PSMA antibodies and uses thereof
- Patent number 9,695,248
- Issue date Jul 4, 2017
- PSMA Development Company, LLC
- Paul J. Maddon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antigen binding proteins
- Patent number 9,624,308
- Issue date Apr 18, 2017
- Pierre Fabre Medicament
- Charlotte Beau-Larvor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
- Patent number 9,580,505
- Issue date Feb 28, 2017
- E.R. Squibb & Sons, L.L.C.
- Alan J. Korman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical composition for treatment of cancer comprising an an...
- Patent number 9,573,993
- Issue date Feb 21, 2017
- Toray Industries, Inc.
- Fumiyoshi Okano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
- Patent number 9,546,216
- Issue date Jan 17, 2017
- E.R. Squibb & Sons, L.L.C.
- Alan J. Korman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies with immune effector activity and that internalize in fo...
- Patent number 9,522,195
- Issue date Dec 20, 2016
- Morphotek, Inc.
- Luigi Grasso
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulators and methods of use
- Patent number 9,458,231
- Issue date Oct 4, 2016
- Stemcentrx, Inc.
- Scott J. Dylla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-DLL3 antibodies
- Patent number 9,353,182
- Issue date May 31, 2016
- Stemcentrx, Inc.
- Robert A Stull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-DLL3 antibody drug conjugates
- Patent number 9,173,959
- Issue date Nov 3, 2015
- Stemcentrx, Inc.
- Robert A Stull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies with immune effector activity and that internalize in fo...
- Patent number 9,144,614
- Issue date Sep 29, 2015
- Morphotek, Inc.
- Nicholas C. Nicolaides
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Anti-DLL3 antibody drug conjugates for treating cancer
- Patent number 9,107,961
- Issue date Aug 18, 2015
- Stemcentrx, Inc.
- Robert A Stull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-FZD10 monoclonal antibodies and methods for their use
- Patent number 9,102,724
- Issue date Aug 11, 2015
- Omeros Corporation
- W. Jason Cummings
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-DLL3 antibody drug conjugates and methods of use
- Patent number 9,089,616
- Issue date Jul 28, 2015
- Stemcentrx, Inc.
- Robert A Stull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-DLL3 antibodies
- Patent number 9,089,615
- Issue date Jul 28, 2015
- Stemcentrx, Inc.
- Robert A Stull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of detection, diagnosis, and monitoring using anti-DLL3 ant...
- Patent number 9,090,683
- Issue date Jul 28, 2015
- Stemcentrx, Inc.
- Robert A Stull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-DLL3 antibody drug conjugates
- Patent number 9,089,617
- Issue date Jul 28, 2015
- Stemcentrx, Inc.
- Robert A Stull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-DLL3 antibody drug conjugates and methods of use
- Patent number 9,011,854
- Issue date Apr 21, 2015
- Stemcentrx, Inc.
- Robert A Stull
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody conjugates against variant NFKBIB and uses thereof
- Patent number 8,999,334
- Issue date Apr 7, 2015
- Viventia Bio Inc.
- Francina C. Chahal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytotoxins comprising modified bouganin toxin for the treatment of...
- Patent number 8,716,234
- Issue date May 6, 2014
- Merck Patent GmbH
- Matthew Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies with immune effector activity and that internalize in en...
- Patent number 8,524,237
- Issue date Sep 3, 2013
- Morphotek, Inc.
- Nicholas C. Nicolaides
- B82 - NANO-TECHNOLOGY
Information Patent Grant
PSMA antibodies and uses thereof
- Patent number 8,470,330
- Issue date Jun 25, 2013
- PSMA Development Company, LLC
- Paul J. Maddon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against a cancer-associated epitope of variant NFKBIB an...
- Patent number 8,426,561
- Issue date Apr 23, 2013
- Francina C. Chahal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
DLL3 MODULATORS AND METHODS OF USE
- Publication number 20170274094
- Publication date Sep 28, 2017
- AbbVie Stemcentrx LLC
- ROBERT A. STULL
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF MAKING DLL3 ANTIBODY DRUG CONJUGATES
- Publication number 20170266314
- Publication date Sep 21, 2017
- AbbVie Stemcentrx LLC
- ROBERT A. STULL
- G01 - MEASURING TESTING
Information Patent Application
ANTI-DLL3 ANTIBODY DRUG CONJUGATES FOR TREATING CANCER
- Publication number 20170266315
- Publication date Sep 21, 2017
- AbbVie Stemcentrx LLC
- ROBERT A. STULL
- G01 - MEASURING TESTING
Information Patent Application
Method of Treating Ovarian and Renal Cancer Using Antibodies Agains...
- Publication number 20170267750
- Publication date Sep 21, 2017
- CELLDEX THERAPEUTICS, INC.
- Kam Fai Tse
- B82 - NANO-TECHNOLOGY
Information Patent Application
ANTI-DLL3 ANTIBODY DRUG CONJUGATES
- Publication number 20170266312
- Publication date Sep 21, 2017
- AbbVie Stemcentrx LLC
- ROBERT A. STULL
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF DELIVERING DLL3 ANTIBODY DRUG CONJUGATES
- Publication number 20170266313
- Publication date Sep 21, 2017
- AbbVie Stemcentrx LLC
- ROBERT A. STULL
- G01 - MEASURING TESTING
Information Patent Application
NOVEL MODULATORS AND METHODS OF USE
- Publication number 20170081419
- Publication date Mar 23, 2017
- AbbVie Stemcentrx LLC
- Scott J. Dylla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-FZD10 MONOCLONAL ANTIBODIES AND METHODS FOR THEIR USE
- Publication number 20160333107
- Publication date Nov 17, 2016
- Omeros Corporation
- W. Jason Cummings
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR NON-MYELOABLATIVE CONDITIONING
- Publication number 20160324982
- Publication date Nov 10, 2016
- President and Fellows of Harvard College
- David T. Scadden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TO THE B12-TRANSCOBALAMIN RECEPTOR
- Publication number 20160130354
- Publication date May 12, 2016
- THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
- Edward V. Quadros
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies With Immune Effector Activity and that Internalize In Fo...
- Publication number 20160058885
- Publication date Mar 3, 2016
- Morphotek, Inc.
- Luigi Grasso
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL ANTIGEN BINDING PROTEINS AND THEIR USE AS ADDRESSING PRODUCT...
- Publication number 20160046725
- Publication date Feb 18, 2016
- PIERRE FABRE MEDICAMENT
- Charlotte Beau-Larvor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING CANCER
- Publication number 20150125445
- Publication date May 7, 2015
- University of Virginia Patent Foundation, d/b/a University of Virginia Licens...
- John C. Herr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DLL3 MODULATORS AND METHODS OF USE
- Publication number 20140370037
- Publication date Dec 18, 2014
- Stem CentRx, Inc.
- ROBERT A STULL
- G01 - MEASURING TESTING
Information Patent Application
DLL3 MODULATORS AND METHODS OF USE
- Publication number 20140364590
- Publication date Dec 11, 2014
- Stem CentRx, Inc.
- ROBERT A STULL
- G01 - MEASURING TESTING
Information Patent Application
DLL3 MODULATORS AND METHODS OF USE
- Publication number 20140363455
- Publication date Dec 11, 2014
- Stem CentRx, Inc.
- ROBERT A STULL
- G01 - MEASURING TESTING
Information Patent Application
DLL3 MODULATORS AND METHODS OF USE
- Publication number 20140364593
- Publication date Dec 11, 2014
- Stem CentRx, Inc.
- ROBERT A STULL
- G01 - MEASURING TESTING
Information Patent Application
DLL3 MODULATORS AND METHODS OF USE
- Publication number 20140363826
- Publication date Dec 11, 2014
- Stem CentRx, Inc.
- ROBERT A STULL
- G01 - MEASURING TESTING
Information Patent Application
DLL3 MODULATORS AND METHODS OF USE
- Publication number 20140363887
- Publication date Dec 11, 2014
- Stem CentRx, Inc.
- ROBERT A STULL
- G01 - MEASURING TESTING
Information Patent Application
PSMA ANTIBODIES AND USES THEREOF
- Publication number 20140286859
- Publication date Sep 25, 2014
- PSMA Development Company, LLC
- Paul J. Maddon
- G01 - MEASURING TESTING
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST HER2
- Publication number 20140170148
- Publication date Jun 19, 2014
- GENMAB A/S
- Bart De Goeij
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Conditionally active anti-epidermal growth factor receptor antibodi...
- Publication number 20140170159
- Publication date Jun 19, 2014
- Ge Wei
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR MACROMOLECULAR DRUG DELIVERY
- Publication number 20140080766
- Publication date Mar 20, 2014
- Massachusetts Institute of Technology
- Christopher Michael Pirie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY CONJUGATES AGAINST VARIANT NFKBIB AND USES THEREOF
- Publication number 20130344076
- Publication date Dec 26, 2013
- Viventia Bio Inc.
- Francina C. CHAHAL
- G01 - MEASURING TESTING
Information Patent Application
Antibody Scaffold For Homogenous Conjugation
- Publication number 20130330350
- Publication date Dec 12, 2013
- Medimmune, LLC
- Nazzareno Dimasi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL MODULATORS AND METHODS OF USE
- Publication number 20130302355
- Publication date Nov 14, 2013
- Scott J. Dylla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Conditionally active anti-epidermal growth factor receptor antibodi...
- Publication number 20130266579
- Publication date Oct 10, 2013
- Ge Wei
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of Treating Ovarian and Renal Cancer Using Antibodies Agains...
- Publication number 20130202527
- Publication date Aug 8, 2013
- CELLDEX THERAPEUTICS, INC.
- Kam Fai Tse
- B82 - NANO-TECHNOLOGY
Information Patent Application
ANTIBODIES TO THE B12-TRANSCOBALAMIN RECEPTOR
- Publication number 20130164309
- Publication date Jun 27, 2013
- THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
- Edward V. Quadros
- G01 - MEASURING TESTING
Information Patent Application
HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH LIGAND 1 (PD-L1)
- Publication number 20130122014
- Publication date May 16, 2013
- Medarex, Inc.
- Alan J. Korman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

the drug being a ribosomal inhibitory protein,(RIP-i or RIP-II)

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Anti-DLL3 antibody drug conjugates for treating cancer

Methods of delivering DLL3 antibody drug conjugates

Kits containing DLL3 antibody drug conjugates

Anti-DLL3 antibody drug conjugates

Anti-FZD10 monoclonal antibodies and methods for their use

Anti-DLL3 antibody drug conjugates for treating cancer

Anti-DLL3 antibody drug conjugates

Methods of making DLL3 antibody drug conjugates

PSMA antibodies and uses thereof

Antigen binding proteins

Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

Pharmaceutical composition for treatment of cancer comprising an an...

Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

Antibodies with immune effector activity and that internalize in fo...

Modulators and methods of use

Anti-DLL3 antibodies

Anti-DLL3 antibody drug conjugates

Antibodies with immune effector activity and that internalize in fo...

Anti-DLL3 antibody drug conjugates for treating cancer

Anti-FZD10 monoclonal antibodies and methods for their use

Anti-DLL3 antibody drug conjugates and methods of use

Anti-DLL3 antibodies

Methods of detection, diagnosis, and monitoring using anti-DLL3 ant...

Anti-DLL3 antibody drug conjugates

Anti-DLL3 antibody drug conjugates and methods of use

Antibody conjugates against variant NFKBIB and uses thereof

Cytotoxins comprising modified bouganin toxin for the treatment of...

Antibodies with immune effector activity and that internalize in en...

PSMA antibodies and uses thereof

Antibodies against a cancer-associated epitope of variant NFKBIB an...

Patents Applicationslast 30 patents

DLL3 MODULATORS AND METHODS OF USE

METHODS OF MAKING DLL3 ANTIBODY DRUG CONJUGATES

ANTI-DLL3 ANTIBODY DRUG CONJUGATES FOR TREATING CANCER

Method of Treating Ovarian and Renal Cancer Using Antibodies Agains...

ANTI-DLL3 ANTIBODY DRUG CONJUGATES

METHODS OF DELIVERING DLL3 ANTIBODY DRUG CONJUGATES

NOVEL MODULATORS AND METHODS OF USE

ANTI-FZD10 MONOCLONAL ANTIBODIES AND METHODS FOR THEIR USE

COMPOSITIONS AND METHODS FOR NON-MYELOABLATIVE CONDITIONING

ANTIBODIES TO THE B12-TRANSCOBALAMIN RECEPTOR

Antibodies With Immune Effector Activity and that Internalize In Fo...

NOVEL ANTIGEN BINDING PROTEINS AND THEIR USE AS ADDRESSING PRODUCT...

COMPOSITIONS AND METHODS FOR TREATING CANCER

DLL3 MODULATORS AND METHODS OF USE

DLL3 MODULATORS AND METHODS OF USE

DLL3 MODULATORS AND METHODS OF USE

DLL3 MODULATORS AND METHODS OF USE

DLL3 MODULATORS AND METHODS OF USE

DLL3 MODULATORS AND METHODS OF USE

PSMA ANTIBODIES AND USES THEREOF

BISPECIFIC ANTIBODIES AGAINST HER2

Conditionally active anti-epidermal growth factor receptor antibodi...

COMPOSITIONS AND METHODS FOR MACROMOLECULAR DRUG DELIVERY

ANTIBODY CONJUGATES AGAINST VARIANT NFKBIB AND USES THEREOF

Antibody Scaffold For Homogenous Conjugation

NOVEL MODULATORS AND METHODS OF USE

Conditionally active anti-epidermal growth factor receptor antibodi...

Method of Treating Ovarian and Renal Cancer Using Antibodies Agains...

ANTIBODIES TO THE B12-TRANSCOBALAMIN RECEPTOR

HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH LIGAND 1 (PD-L1)